Also trades as: 0M40.L (LSE) · $vol 0M
ZYNE NASDAQ
Zynerba Pharmaceuticals, Inc.
1W: +1.6%
1M: -3.7%
3M: +271.4%
1Y: +90.9%
3Y: -64.0%
5Y: -81.4%
$1.30
Last traded 2023-10-13 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-37M
Net Income
+3.7% YoY
$-32M
Free Cash Flow
-24.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-85.8%
ROA-68.9%
ROIC455.4%
Valuation
P/E-1.6
P/B1.2
EV/EBITDA0.5
Leverage
Debt/Equity0.01
Current Ratio3.43
Interest Cov.-111.1x
Quality Scores
Piotroski F2/9
Altman Z-10.82
Beneish M0.00